P., Iwuanyanwu, T., Harnik, M., 18,19-Dihydroxycorticosterone: new metabolite in human urine,Endocr Iwuanyanwu, T., Lewicka, S., Vecsei, P., Abdelhamid, S., and Harnik, M., Urinary18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patientsdoi:10.1080/...
19-Noraldosterone 来自 Taylor & Francis 喜欢 0 阅读量: 20 作者: Y Takeda 摘要: P., Iwuanyanwu, T., Harnik, M., 18,19-Dihydroxycorticosterone: new metabolite in human urine,Endocr Iwuanyanwu, T., Lewicka, S., Vecsei, P., Abdelhamid, S., and Harnik, M., Urinary18,19-...
CAS号: 76025-75-7 英文名: 19-Noraldosterone 英文别名: 19-Noraldosterone 中文名: 中文别名: CBNumber: CB41238783 分子式: 分子量: 0 MOL File: 76025-75-7.mol 化学性质 安全信息 用途 供应商 1 19-Noraldosterone化学性质 安全信息...
These results suggest that circulating aldosterone, 19-noraldosterone, and renal 11β-hydroxysteroid dehydrogenase2 do not contribute to the pathogenesis of PIH. Regulatory factors that cause the down-regulation of the mineralocorticoid receptor in PIH should be clarified. 展开 关键词:...
19-Nordeoxycorticosterone (19-norDOC) is a powerful mineralocorticoid that has been postulated to play a role in the pathogenesis of some forms of hypertension in the rat. We measured the daily excretion of 19-norDOC, aldosterone, and corticosterone in intact male and female SR/jr rats for 20...
19-Noraldosterone, a new mineralocorticoid. possesses potent mineralocorticoid and hypertensinogenic activity [4, 5]. 18, 19-Dihydroxycorticosterone [18, 19-(OH)2-B] and 18-hydroxy-19norcorticosteron... Y Takeda,I Miyamori - 《Endocrine Journal》 被引量: 0发表: 1994年 Analysis of Cavitation...
1990 Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. J Steroid Biochem Mol Biol. 37:599 - 604.Takeda, Y., Lewicka, S., Koch, S., Bige, K., Vecsei, P., Abdelhimid, S., Cojocaru, M., and ...
Takeda, Y., Iki, K., Miyamori, I., and Takeda, R., Formation of 18-deoxy-19-noraldosterone by a human aldos- terone-producing adenoma, Steroids, 58, 282, 1993 .Takeda Y, Iki K, Miyamori I, Takeda R (1993). Formation of 18-deoxy-19-noraldosteroneby a human aldosterone-...
Urinary levels of 19‐noraldosterone were higher in SHRSP (11 ± 4.9 pmol/day) than in SHR (7 ± 4.0 pmol/day) at 9 weeks of age.5. Adrenal mineralocorticoids are suggested to be responsible for the abnormal vascular reactivity observed in SHRSP. Relatively elevated levels of 19‐nor...
Takeda Y, Miyamori I, Yoneda T, Furukawa K, Inaba S, Ito Y, and Takeda R. Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1995; 1: S20-S22....